Skip to content
Search

Latest Stories

NHS crisis debate: Strategic funding and capacity issues take center stage

NHS crisis debate: Strategic funding and capacity issues take center stage
Experts and public discuss future-proofing healthcare amidst alarming statistics and systemic challenges

"There is a lack of strategic thinking to address funding in pharmacy and get that right. We could get so much more capacity and reduce demand and bottlenecks in secondary care,” a pharmacist during a recent debate on Channel 4 said.

The NHS in Crisis hosted by Krishnan Guru-Murthy brought together a diverse audience of medical professionals and the public, who engaged in a heated discussion on the critical issues facing the NHS.


"A politician- free debate", Guru-Murthy introduced the "special" debate around the future of NHS post elections.

The panel was chaired by Matthew Taylor, Chief Executive of the NHS Confederation; Sarah Woolnough, Chief Executive - The King's Fund; Chaand Nagpaul, Former Chair of the British Medical Association (BMA); Dr. Adrian Boyle, President of the Royal College of Emergency Medicine, and Sarah Wollaston, a GP , Former MP and former NHS Devon.

They tackled pressing questions about the NHS's current funding model and the widespread challenges in hospital care, A&E, primary care, secondary care, nursing, and pharmacy.

The issue of NHS GP contracts being unfit for purpose and the crisis facing pharmacies was raised amongst several concerns that around maternity care, emergency care and the state of hospitals, and metal health.

According to the pharmacist who owns a group of pharmacies in North of England strategic thinking and "better funding for pharmacies could alleviate bottlenecks in secondary care."

“I am not a doctor. I am a pharmacist and we are having a crisis of our own,” he stated. “We see at least 1.6 million people every day, and everything we do impacts secondary care and primary care and vice versa," added emphasising the interconnectedness of pharmacy and primary and secondary care.

Another pharmacist echoed these concerns, stressing the importance of future-proofing community pharmacies to prevent serious health conditions from worsening.

She stated, “There have been a huge number of closures in community pharmacies."

"How are we going to ensure that we are able to future-proof ourselves so people can use primary care in the right way and not end up in a more serious condition?”

Demand Vs. Capacity

Chaand Nagpaul, former chair of the BMA, addressed these queries by highlighting the mismatch between demand and capacity.

He pointed out that general practice sees over 1 million patients daily, a number that has increased by 30 million in the past five years. “Ultimately, we have a mismatch between demand and capacity,” he explained.

“In general practice, we are seeing over 1 million patients on a daily basis. That has increased by 30 million in the last five years.

"About 1,800 equivalent full-time GPs are missing from the system, placing huge increasing demand every year," he stated.

"We do not have the capacity to provide the care, and that is why patients have difficulties accessing surgeries. We need an absolute commitment to increasing the number of GPs."

"There is a bizarre, illogical funding problem where some GPs are unable to get jobs because the government gives us money to pay nurses and physiotherapists but not the resources to employ the GPs,” he added.

The debate also circled around state of hospital care, and about increasing funding for the NHS to fix the front door and the backdoor of care.

Measured Hope

Despite the grim statistics and challenging discussions, the panel concluded at the end of the debate programme with a sense of cautious optimism.

"The problems we have are fixable. I was a junior doctor in the 1990s and we were having similar conversations about that and it is cyclical. But I am optimistic that we will be in a better state", Dr. Adrian Boyle said.

Former Chair of BMA said, Nagpaul said, "It is entirely possibly to fix the NHS but it requires political honesty and also de-politicization as well," whereas Sarah Woolnough, Chief Executive - The King's Fund cautioned that the current model need reform to make care better.

They expressed confidence that with the right strategies and commitment, the NHS could overcome its current crisis and continue to serve the public effectively in the long run.

Alarming NHS statistics 

A recent report by the Health Foundation highlighted that over 302,000 patients have been waiting more than a year for treatment, with an average waiting time of 13.9 weeks as of April 2024.

Additionally, A&E performance stood at only 72.1 per cent of patients treated within four hours, and a staggering 439,411 patients experienced waits exceeding 12 hours due to system pressures.

The elective care waiting list for NHS England has ballooned to 7.6 million, underscoring the severe strain on the health service, which has struggled to meet standards since February 2016.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less